Previous studies reported that lncRNA SPRY4‐IT1 upregulates EZH2 to exert oncogenic properties in cholangiocarcinoma and bladder cancer by sponging miR‐101‐3p.10, 20. The gene discussed is EZH2; the disease is urinary bladder carcinoma.